Associate Professor Michael Blazing
Duke Clinical Research Institute, Durham (United States of America)
Comparative efficacy of ezetimibe plus simvastatin combined therapy vs. simvastatin monotherapy for individuals with reduced estimated glomerular filtration rate
Event: ESC Congress 2016
Topic: Drug therapy
Session: Lipid-lowering agents - New perspectives
ESC 365 is supported by
